The present invention provides a method of treating behavioral disorders suc h as attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof a nd the like.
USE OF ISTRADEFYLLINE (KW-6002) FOR THE TREATMENT OF BEHAVIORAL DISORDERS